Kura Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 7.65 M | $149.54 M | 8.25% | 8.80% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.16 M | $139.82 M | 100.00% | 8.23% |
ECOR1 CAPITAL, LLC | 11/14/2024 | 5.81 M | $113.47 M | 0.00% | 6.68% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 5.41 M | $105.74 M | 0.00% | 6.22% |
PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 4.33 M | $84.63 M | -4.58% | 4.98% |
VANGUARD GROUP INC | 11/13/2024 | 4.20 M | $82.14 M | 4.04% | 4.83% |
AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 3.54 M | $69.20 M | 0.00% | 4.07% |
BVF INC/IL | 11/14/2024 | 3.37 M | $65.88 M | -17.40% | 3.88% |
HOLOCENE ADVISORS, LP | 11/14/2024 | 2.69 M | $52.55 M | 0.00% | 3.09% |
STATE STREET CORP | 11/14/2024 | 2.67 M | $52.15 M | -7.48% | 3.07% |
ARMISTICE CAPITAL, LLC | 11/14/2024 | 2.66 M | $51.94 M | 13.11% | 3.06% |
DEEP TRACK CAPITAL, LP | 11/14/2024 | 1.96 M | $38.37 M | 410.32% | 2.26% |
FORESITE CAPITAL MANAGEMENT IV, LLC | 11/14/2024 | 1.85 M | $36.15 M | 0.00% | 2.13% |
COMMODORE CAPITAL LP | 11/14/2024 | 1.80 M | $35.17 M | 12.97% | 2.07% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.78 M | $34.80 M | 2.39% | 2.05% |
FRANKLIN RESOURCES INC | 11/27/2024 | 1.59 M | $28.69 M | 1.48% | 1.83% |
TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 1.42 M | $27.82 M | 0.00% | 1.64% |
SIREN, L.L.C. | 11/13/2024 | 1.34 M | $26.18 B | 100.00% | 1.54% |
MORGAN STANLEY | 11/14/2024 | 1.21 M | $23.58 M | -9.17% | 1.39% |
CITADEL ADVISORS LLC | 11/14/2024 | 1.19 M | $23.23 M | 17.36% | 1.37% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.05 M | $20.59 M | 17.79% | 1.21% |
ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 1.05 M | $20.56 M | -39.24% | 1.21% |
BOXER CAPITAL, LLC | 11/14/2024 | 1.00 M | $19.54 M | 0.00% | 1.15% |
CANDRIAM S.C.A. | 11/13/2024 | 906,482 | $17.71 M | 0.00% | 1.04% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 845,194 | $16.52 M | 148.97% | 0.97% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 709,484 | $13.86 M | -14.71% | 0.82% |
PROSIGHT MANAGEMENT, LP | 11/14/2024 | 705,109 | $13.78 M | 11.94% | 0.81% |
AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 687,785 | $13.44 M | 5.81% | 0.79% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 624,952 | $12.21 M | 2.31% | 0.72% |
SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 610,087 | $11.92 M | -0.12% | 0.70% |
WALLEYE CAPITAL LLC | 11/14/2024 | 571,365 | $11.16 M | 661.00% | 0.66% |
ALETHEA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 553,542 | $10.82 M | 108.17% | 0.64% |
D. E. SHAW & CO., INC. | 11/14/2024 | 423,208 | $8.27 M | 12.64% | 0.49% |
JPMORGAN CHASE & CO | 12/26/2024 | 409,241 | $8.00 M | 0.76% | 0.47% |
DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 408,368 | $7.98 M | -3.57% | 0.47% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 350,415 | $6.85 M | -12.95% | 0.40% |
SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 296,884 | $5.80 B | -64.02% | 0.34% |
ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 294,081 | $5.75 M | -4.13% | 0.34% |
ALGERT GLOBAL LLC | 11/12/2024 | 272,276 | $5.32 M | 4.41% | 0.31% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 256,880 | $5.02 M | -1.97% | 0.30% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 252,770 | $4.94 M | 15.71% | 0.29% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 208,239 | $4.07 M | -23.52% | 0.24% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 205,678 | $4.02 M | -19.62% | 0.24% |
ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 197,000 | $3.85 M | 20.86% | 0.23% |
EVERSEPT PARTNERS, LP | 11/14/2024 | 192,398 | $3.76 M | 166.05% | 0.22% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 189,103 | $3.70 M | 100.00% | 0.22% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 166,526 | $3.25 M | 0.00% | 0.19% |
BARCLAYS PLC | 11/19/2024 | 165,484 | $3.23 M | 104.50% | 0.19% |
WOODLINE PARTNERS LP | 11/14/2024 | 143,207 | $2.80 M | 0.00% | 0.16% |
PROPEL BIO MANAGEMENT, LLC | 11/13/2024 | 130,000 | $2.54 M | 0.00% | 0.15% |
Kura Oncology, Inc.institutional Ownership - FAQ's
During the previous two years, 211 institutional investors and hedge funds held shares of Kura Oncology, Inc.. The most heavily invested institutionals were:
MASSMUTUAL TRUST CO FSB/ADV: 0
SUVRETTA CAPITAL MANAGEMENT, LLC: 7.65 M
BlackRock Funding, Inc. /DE: 7.16 M
EcoR1 Capital, LLC: 5.81 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 5.41 M
Paradigm Biocapital Advisors LP: 4.33 M
94.66% of Kura Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 89.01 M shares in the last 24 months. This purchase volume represents approximately $699.65 M in transactions.